BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22009554)

  • 21. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.
    Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GJ; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR
    Blood; 2011 Feb; 117(5):1492-8. PubMed ID: 21048153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
    Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
    Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.
    Ishdorj G; Streu E; Lambert P; Dhaliwal HS; Mahmud SM; Gibson SB; Banerji V; Marshall AJ; Johnston JB
    Blood Adv; 2019 Jul; 3(14):2188-2198. PubMed ID: 31324639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada.
    Huang SJ; Gerrie AS; Young S; Tucker T; Bruyère H; Hrynchak M; Galbraith P; Al Tourah AJ; Dueck G; Noble MC; Ramadan KM; Tsang P; Hardy E; Sehn LH; Toze CL
    Leuk Res; 2021 Apr; 103():106538. PubMed ID: 33647819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
    Cooper JP; Khajaviyan S; Smith SD; Maloney DG; Shustov AR; Warren EH; Soma LA; Lynch RC; Ujjani C; Till B; Halpern AB; Gopal AK; Deeg HJ; Scott BL; Shadman M
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):390-395. PubMed ID: 30948330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
    Tees MT; Flinn IW
    Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
    Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
    Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.
    Ko BS; Chen LJ; Huang HH; Chen HM; Hsiao FY
    Int J Clin Pract; 2021 Aug; 75(8):e14258. PubMed ID: 33884738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
    Wierda WG; Byrd JC; Abramson JS; Bilgrami SF; Bociek G; Brander D; Brown J; Chanan-Khan AA; Chavez JC; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lim MS; Ma S; Malek S; Mato A; Mosse C; Shadman M; Siddiqi T; Stephens D; Sundaram S; Wagner N; Dwyer M; Sundar H
    J Natl Compr Canc Netw; 2020 Feb; 18(2):185-217. PubMed ID: 32023533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ; Parrish RS; Schichman SA; Zent CS
    Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
    Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
    Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
    Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
    Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
    Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia.
    Nabhan C; Chaffee KG; Slager SL; Galanina N; Achenbach SJ; Schwager SM; Kay NE; Shanafelt TD
    Am J Hematol; 2016 Jul; 91(7):677-80. PubMed ID: 27013143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.